Pharmaceutical formulations and methods of use

Details for Australian Patent Application No. 2006206423 (hide)

Owner PharmaNova Inc. Quay Pharmaceuticals Ltd.

Inventors Violante, Michael R.; Brown, Rodney A.; Curry, Stephen H.; Rubenstein, Michael

Agent Shelston IP

Pub. Number AU-A-2006206423

PCT Pub. Number WO2006/078811

Priority 60/645,857 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

International Classifications

A61K 9/36 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/195 (2006.01)

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/078811 Priority application(s): WO2006/078811

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006206426-Cellular microarrays for screening differentiation factors

2006206421-Method for the preparation of maytansinoid esters